{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:51:09Z","timestamp":1769694669511,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10142-023-00998-1","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T07:03:11Z","timestamp":1677654191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bioinformatics analysis based on high-throughput sequencing data to identify hub genes related to different clinical types of COVID-19"],"prefix":"10.1007","volume":"23","author":[{"given":"Shengying","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiong","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"issue":"18","key":"998_CR1","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/acschemneuro.0c00434","volume":"11","author":"FJ Barrantes","year":"2020","unstructured":"Barrantes FJ (2020) Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses. ACS Chem Neurosci 11(18):2793\u20132803","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"998_CR2","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41467-019-09734-5","volume":"10","author":"J Bertran-Alamillo","year":"2019","unstructured":"Bertran-Alamillo J, Cattan V, Schoumacher M et al (2019) AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy. Nat Commun 10(1):1812","journal-title":"Nat Commun"},{"issue":"8","key":"998_CR3","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1111\/jcmm.16385","volume":"25","author":"J Cheng","year":"2021","unstructured":"Cheng J, Zhou J, Fu S et al (2021) Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2. J Cell Mol Med 25(8):4157\u20134165","journal-title":"J Cell Mol Med"},{"issue":"11","key":"998_CR4","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/jth.15517","volume":"19","author":"JH Chow","year":"2021","unstructured":"Chow JH, Yin Y, Yamane DP et al (2021) Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis. J Thromb Haemost JTH 19(11):2814\u20132824","journal-title":"J Thromb Haemost JTH"},{"issue":"2","key":"998_CR5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jmv.26398","volume":"93","author":"X Cui","year":"2021","unstructured":"Cui X, Zhao Z, Zhang T et al (2021) A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J Med Virol 93(2):1057\u20131069","journal-title":"J Med Virol"},{"issue":"15","key":"998_CR6","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","volume":"384","author":"N Dagan","year":"2021","unstructured":"Dagan N, Barda N, Kepten E et al (2021) BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med 384(15):1412\u20131423","journal-title":"N Engl J Med"},{"issue":"6","key":"998_CR7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00428-014-1577-7","volume":"464","author":"B Davidson","year":"2014","unstructured":"Davidson B, Nymoen DA, Elgaaen BV et al (2014) BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma. Virchows Archiv 464(6):701\u2013707","journal-title":"Virchows Archiv"},{"key":"998_CR8","first-page":"m1985","volume":"369","author":"AB Docherty","year":"2020","unstructured":"Docherty AB, Harrison EM, Green CA et al (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ (clinical Research Ed) 369:m1985","journal-title":"BMJ (clinical Research Ed)"},{"issue":"1","key":"998_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jmii.2020.05.001","volume":"54","author":"Z Gao","year":"2021","unstructured":"Gao Z, Xu Y, Sun C et al (2021) A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect 54(1):12\u201316","journal-title":"J Microbiol Immunol Infect"},{"key":"998_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101615","volume":"36","author":"E Gkogkou","year":"2020","unstructured":"Gkogkou E, Barnasas G, Vougas K et al (2020) Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Redox Biol 36:101615","journal-title":"Redox Biol"},{"issue":"5","key":"998_CR11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2020.25699","volume":"325","author":"T Hampton","year":"2021","unstructured":"Hampton T (2021) Autoantibodies May Drive COVID-19 Blood Clots. JAMA 325(5):425","journal-title":"JAMA"},{"issue":"2","key":"998_CR12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181(2):271-280.e8","journal-title":"Cell"},{"issue":"1","key":"998_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","volume":"12","author":"H Hua","year":"2019","unstructured":"Hua H, Kong Q, Zhang H et al (2019) Targeting mTOR for cancer therapy. J Hematol Oncol 12(1):71","journal-title":"J Hematol Oncol"},{"issue":"6","key":"998_CR14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1053\/j.gastro.2022.02.005","volume":"162","author":"BZ Huang","year":"2022","unstructured":"Huang BZ, Sidell MA, Wu BU et al (2022) Pre-Existing Pancreatitis and Elevated Risks of COVID-19 Severity and Mortality. Gastroenterology 162(6):1758-1760.e3","journal-title":"Gastroenterology"},{"key":"998_CR15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ijid.2020.12.078","volume":"103","author":"J Ihlow","year":"2021","unstructured":"Ihlow J, Michaelis E, Greuel S et al (2021) B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased. Int J Infect Dis 103:628\u2013635","journal-title":"Int J Infect Dis"},{"issue":"6","key":"998_CR16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/epi-2020-0349","volume":"13","author":"BP Jit","year":"2021","unstructured":"Jit BP, Qazi S, Arya R et al (2021) An immune epigenetic insight to COVID-19 infection. Epigenomics 13(6):465\u2013480","journal-title":"Epigenomics"},{"issue":"20","key":"998_CR17","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1128\/JVI.74.20.9637-9645.2000","volume":"74","author":"A Krithivas","year":"2000","unstructured":"Krithivas A, Young DB, Liao G et al (2000) Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 74(20):9637\u20139645","journal-title":"J Virol"},{"key":"998_CR18","doi-asserted-by":"crossref","unstructured":"Lee JH, Berger JM (2019) Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II. Genes 10 (11):859","DOI":"10.3390\/genes10110859"},{"key":"998_CR19","doi-asserted-by":"crossref","first-page":"22081","DOI":"10.1038\/srep22081","volume":"6","author":"RX Leng","year":"2016","unstructured":"Leng RX, Pan HF, Liu J et al (2016) Evidence for genetic association of TBX21 and IFNG with systemic lupus erythematosus in a Chinese Han population. Sci Rep 6:22081","journal-title":"Sci Rep"},{"issue":"3","key":"998_CR20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/0008-5472.CAN-16-2350","volume":"7","author":"S Li","year":"2017","unstructured":"Li S, Sun A, Liang X et al (2017) Histone demethylase PHF8 promotes progression and metastasis of gastric cancer. Am J Cancer Res 7(3):448\u2013461","journal-title":"Am J Cancer Res"},{"issue":"Suppl 2","key":"998_CR21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12920-022-01243-7","volume":"15","author":"C Li","year":"2022","unstructured":"Li C, Wang R, Wu A et al (2022) SARS-COV-2 as potential microRNA sponge in COVID-19 patients. BMC Med Genomics 15(Suppl 2):94","journal-title":"BMC Med Genomics"},{"issue":"7821","key":"998_CR22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas C, Wong P, Klein J et al (2020) Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584(7821):463\u2013469","journal-title":"Nature"},{"issue":"7","key":"998_CR23","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/cid\/ciab608","volume":"74","author":"SF Lumley","year":"2022","unstructured":"Lumley SF, Rodger G, Constantinides B et al (2022) An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status. Clin Infect Dis 74(7):1208\u20131219","journal-title":"Clin Infect Dis"},{"issue":"2","key":"998_CR24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JVI.01165-09","volume":"84","author":"Z Mansuroglu","year":"2010","unstructured":"Mansuroglu Z, Josse T, Gilleron J et al (2010) Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. J Virol 84(2):928\u2013939","journal-title":"J Virol"},{"issue":"5","key":"998_CR25","first-page":"262","volume":"77","author":"LD Manzanares-Meza","year":"2020","unstructured":"Manzanares-Meza LD, Medina-Contreras O (2020) SARS-CoV-2 and influenza: a comparative overview and treatment implications. Boletin Medico Del Hospital Infantil De Mexico 77(5):262\u2013273","journal-title":"Boletin Medico Del Hospital Infantil De Mexico"},{"issue":"3","key":"998_CR26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10142-022-00841-z","volume":"22","author":"SZ Mousavi","year":"2022","unstructured":"Mousavi SZ, Rahmanian M, Sami A (2022) Organ-specific or personalized treatment for COVID-19: rationale, evidence, and potential candidates. Funct Integr Genomics 22(3):429\u2013433","journal-title":"Funct Integr Genomics"},{"key":"998_CR27","doi-asserted-by":"crossref","unstructured":"Napolitano V, Dabrowska A, Schorpp K et al (2022) Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell Chem Biol 29(5):774\u2013784.e8","DOI":"10.1016\/j.chembiol.2021.11.006"},{"issue":"2","key":"998_CR28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/bju.15573","volume":"129","author":"DE Nassau","year":"2022","unstructured":"Nassau DE, Best JC, Kresch E et al (2022) Impact of the SARS-CoV-2 virus on male reproductive health. BJU Int 129(2):143\u2013150","journal-title":"BJU Int"},{"key":"998_CR29","doi-asserted-by":"crossref","unstructured":"Ortenzi F, Albanese E, Fadda M (2020) A Transdisciplinary Analysis of COVID-19 in Italy: The Most Affected Country in Europe. Int J Environ Res Public Health 17(24):9488","DOI":"10.3390\/ijerph17249488"},{"issue":"9","key":"998_CR30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1474-4422(20)30269-6","volume":"19","author":"A Pavel","year":"2020","unstructured":"Pavel A, Murray DK, Stoessl AJ (2020) COVID-19 and selective vulnerability to Parkinson\u2019s disease. Lancet Neurol 19(9):719","journal-title":"Lancet Neurol"},{"issue":"1","key":"998_CR31","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","volume":"11","author":"H Peckham","year":"2020","unstructured":"Peckham H, de Gruijter NM, Raine C et al (2020) Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 11(1):6317","journal-title":"Nat Commun"},{"issue":"10","key":"998_CR32","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/j.apsb.2021.04.023","volume":"11","author":"Q Qiao","year":"2021","unstructured":"Qiao Q, Liu X, Yang T et al (2021) Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design. Acta Pharmaceutica Sinica B 11(10):3060\u20133091","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"23","key":"998_CR33","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A et al (2021) Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. New Engl J Med 384(23):2187\u20132201","journal-title":"New Engl J Med"},{"key":"998_CR34","doi-asserted-by":"crossref","unstructured":"Sah P, Fitzpatrick MC, Zimmer CF et al (2021) Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis. Proc Natl Acad Sci USA 118 (34):e2109229118","DOI":"10.1073\/pnas.2109229118"},{"key":"998_CR35","doi-asserted-by":"crossref","unstructured":"Silverstein NJ, Wang Y, Manickas-Hill Z et al (2022) Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection. eLife 11: e74681","DOI":"10.7554\/eLife.74681"},{"issue":"14","key":"998_CR36","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.18632\/oncotarget.14893","volume":"8","author":"A Tang","year":"2017","unstructured":"Tang A, Gao K, Chu L et al (2017) Aurora kinases: novel therapy targets in cancers. Oncotarget 8(14):23937\u201323954","journal-title":"Oncotarget"},{"issue":"6508","key":"998_CR37","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1126\/science.abc8665","volume":"369","author":"M Thoms","year":"2020","unstructured":"Thoms M, Buschauer R, Ameismeier M et al (2020) Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science (New York, N.Y.) 369(6508):1249\u20131255","journal-title":"Science (New York, N.Y.)"},{"key":"998_CR38","doi-asserted-by":"crossref","unstructured":"Uddin M, Mustafa F, Rizvi TA et al (2020) SARS-CoV-2\/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. Viruses 12(5):526","DOI":"10.3390\/v12050526"},{"key":"998_CR39","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103032","volume":"153","author":"B Wang","year":"2020","unstructured":"Wang B, Huang Y (2020) Which type of cancer patients are more susceptible to the SARS-COX-2: Evidence from a meta-analysis and bioinformatics analysis. Crit Rev Oncol Hematol 153:103032","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"998_CR40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41392-021-00716-y","volume":"6","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhu X, Jiang XM et al (2021) Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients. Signal Transduct Target Ther 6(1):300","journal-title":"Signal Transduct Target Ther"},{"key":"998_CR41","unstructured":"WHO (2022) Weekly epidemiological update on COVID-19 - 27 April 2022. https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---27-april-2022. Accessed 29 Apr 2022"},{"key":"998_CR42","doi-asserted-by":"crossref","unstructured":"Wicik Z, Eyileten C, Jakubik D et al (2020) ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors. J Clin Med 9(11):3743","DOI":"10.3390\/jcm9113743"},{"issue":"5","key":"998_CR43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.euf.2020.05.009","volume":"6","author":"M Yang","year":"2020","unstructured":"Yang M, Chen S, Huang B et al (2020) Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications. Eur Urol Focus 6(5):1124\u20131129","journal-title":"Eur Urol Focus"},{"issue":"1","key":"998_CR44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41065-020-00168-4","volume":"158","author":"J Yang","year":"2021","unstructured":"Yang J, Chen T, Zhou Y (2021) Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes. Hereditas 158(1):4","journal-title":"Hereditas"},{"issue":"6","key":"998_CR45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the `Cytokine Storm\u2019 in COVID-19. J Infect 80(6):607\u2013613","journal-title":"J Infect"},{"issue":"8","key":"998_CR46","doi-asserted-by":"crossref","first-page":"678","DOI":"10.21037\/atm-21-936","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wu Y, Li S et al (2021) Bioinformatic and mouse model reveal the potential high vulnerability of Leydig cells on SARS-CoV-2. Ann Transl Med 9(8):678","journal-title":"Ann Transl Med"},{"key":"998_CR47","volume":"298","author":"LF Zhao","year":"2022","unstructured":"Zhao LF, Qi FY, Zhang JG et al (2022) Identification of the upstream regulators of KDM5B in gastric cancer. Life Sci 298:120458","journal-title":"Life Sci"},{"issue":"8","key":"998_CR48","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.18632\/aging.102988","volume":"12","author":"A Zhavoronkov","year":"2020","unstructured":"Zhavoronkov A (2020) Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections. Aging 12(8):6492\u20136510","journal-title":"Aging"},{"issue":"1","key":"998_CR49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41392-021-00853-4","volume":"6","author":"S Zu","year":"2021","unstructured":"Zu S, Luo D, Li L et al (2021) Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry. Signal Transduct Target Ther 6(1):435","journal-title":"Signal Transduct Target Ther"}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-023-00998-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-023-00998-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-023-00998-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T19:36:30Z","timestamp":1679340990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-023-00998-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["998"],"URL":"https:\/\/doi.org\/10.1007\/s10142-023-00998-1","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"9 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal ethics"}},{"value":"The results\/data\/figures in this manuscript have not been published elsewhere, nor are they under consideration (from you or one of your Contributing Authors) by another publisher.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"71"}}